Pentapharm Marktanteilsanalyse für Juni 2026

Prionex® is a 10% aqueous solution of a polypeptide fraction of highly purified dermal collagen of porcine origin which has excellent protein stabilizing properties. Prionex® is prepared by partial hydrolysis and is terminally sterilized. It is free from cartilage, bone and plasma components and is therefore a pure form of partially hydrolyzed gelatine type A. Additionally, Prionex® is free from nucleic acids, polysaccharides and lipids as well as any additives. APPLICATION: Prionex® can be used advantageously to optimize the stability of biological activity; improve conditions for lyophilisation and heat treatment; eliminate the use of bovine-derived materials; prevent denaturation by chaotropic agents or solvents; and to extend the shelf life of enzymes and proteins. Additionally, Prionex® is additive free and can serve as a high consistency stabilizer. Prionex® is a proven stabilizer for in-vitro diagnostic (IVD) applications: • Protein stabilization • Preservation of biological activity • Adsorption prevention • Shelf-life extension • Lyophilization and heat treatment excipient • Blocking agent in immunoassays to reduce non-specific binding ADVANTAGES Prionex® is freely soluble in water, diluted electrolyte solutions, glycerol and DMSO as well as in diluted ethanol and ammonium sulphate solutions below 20% saturation. It can be used beneficially to: • Optimize the stability of biological activity • Improve conditions for lyophilisation and heat treatment • Avoid denaturation by chaotropic agents or solvents • Extends shelf life for enzymes and proteins • High consistency stabilizer • Non-toxic and non-antigenic